Skip to main content

Find Clinical Trials

Home
Conditions
Hemorrhagic Fevers, Viral

Clinical trial condition

Hemorrhagic Fevers, Viral

Explore clinical trials studying Hemorrhagic Fevers, Viral. Study availability and eligibility vary by location and protocol.

352 public trials 34 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Fevers, Viral trial results

Completed

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults

NCT00270699

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +9 more
Locations: Center for Immunization Research, Johns Hopkins School of Public Health Baltimore, Maryland, United States

View Trial Details

Completed

Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine

NCT00920517

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +8 more
Locations: Center for Immunization Research Baltimore, Maryland, United States

View Trial Details

Completed

Safety and Immune Response to an Investigational Dengue Type 2 Vaccine

NCT01073306

Conditions: Arbovirus Infections, Dengue, Dengue Virus, +9 more
Locations: Johns Hopkins Project SAVE, Center for Immunization Research Washington D.C., District of Columbia, United States

View Trial Details

Completed

Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus

NCT00919178

Conditions: Arbovirus Infections, Dengue, Dengue Hemorrhagic Fever, +10 more
Locations: Center for Immunization Research, Johns Hopkins School of Public Health Baltimore, Maryland, United States

University of Vermont Vaccine Testing Center Burlington, Vermont, United States

View Trial Details

Completed

Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine

NCT01072786

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +8 more
Locations: Center for Immunization Research, Johns Hopkins School of Public Health Washington D.C., District of Columbia, United States

Center for Immunization Research, Johns Hopkins School of Public Health Baltimore, Maryland, United States

Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC) Burlington, Vermont, United States

University of Vermont Vaccine Testing Center Burlington, Vermont, United States

View Trial Details

Completed

Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine

NCT01084291

Conditions: Arbovirus Infections, Dengue, Dengue Virus, +9 more
Locations: Fletcher Allen Health Care (FAHC) General Clinical Research Center (GCRC) Burlington, Vermont, United States

University of Vermont Vaccine Testing Center Burlington, Vermont, United States

View Trial Details

Completed

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy Adults

NCT00712803

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +7 more
Locations: Center for Immunization Research, Johns Hopkins School of Public Health Washington D.C., District of Columbia, United States

Center for Immunization Research, Johns Hopkins University of Public Health Baltimore, Maryland, United States

View Trial Details

Completed

Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)

NCT00982137

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +19 more
Locations: Herston, Queensland, Australia

View Trial Details

Completed

Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus

NCT01353040

Conditions: Animal Diseases, Filoviridae Infections, Hemorrhagic Fevers, Viral, +8 more
Locations: West Coast Clinical Trials Cypress, California, United States

View Trial Details

Completed

Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus

NCT01353027

Conditions: Ebola Hemorrhagic Fever, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: New Orleans Center for Clinical Research - Knoxville Knoxville, Tennessee, United States

View Trial Details